Atlas Trials

Total Marrow Irradiation & Autologous Stem Cell Transplantation for Relapsed or Refractory Myeloma

Clinical trial NCT00800059 · UNKNOWN

Trial details

NCT number
NCT00800059
Sponsor
Ottawa Hospital Research Institute
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2008-11-01
Primary completion
2020-11-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.